Reboxetine showed a higher analgesic potency than placebo , with a statistically significant superiority in capsaicinirritated skin -- in the objective tests ( laser SEP , P < 0.0001 for N1 and P = 0.0002 for P2 ) as well as in the subjective pain measurements ( VAS , P < 0.0003 ) .
